MDGL vs TRV · rev $675.6M vs P/E 14, rev $12.15B
Madrigal Pharmaceuticals Inc (MDGL) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
Latest reported TRV revenue for 2026-06-30 was $12.15B. Net income was $2.21B. Revenue was up 1.9% from 2026-03-31 to 2026-06-30. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
MDGL currently screens at market cap $11.56B. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the MDGL and TRV stock pages for the full models.
Not investment advice.